Abstract

This study aims to evaluate the association between gestational diabetes mellitus (GDM) at first pregnancy and the incidence of cancer within 10 years postpartum. We used customized health information data from the National Health Insurance Corporation (NHIC). This retrospective cohort study included data from women who were not previously diagnosed with diabetes or any kind of malignancy in the National Health Screening Examination through the NHIC during 2002–2003, and only women who had their first delivery between 2004 and 2005 was included. Follow-up cancer diagnosis was carried out up until 2015. Among the 102,900 primiparous women, 4970 (4.83%) were diagnosed with GDM. During 10 year total follow-up period, 6569 (6.38%) cases of primary cancer were identified. The incidence of cancer was higher in women with GDM and the most common type of cancer was thyroid cancer, followed by breast cancer. On the basis of survival analysis, we adopted the Cox proportional hazards model and found that GDM was positively associated with cancer, particularly in thyroid cancer (HR: 1.27, 95% CI: 1.054–1.532, p = 0.012). However, the incidence of other malignancies (including ovarian and breast cancers) were not significantly associated with GDM, though they did show positive trends. Our findings suggest that GDM is associated with the incidence of cancer, particular thyroid cancer.

Highlights

  • Gestational diabetes mellitus (GDM) is defined as a carbohydrate intolerance of variable severity with onset or first recognition occurring during pregnancy [1,2]

  • We excluded 1634 women who were previously diagnosed as having diabetes, 57 with previous cancer and 7108 with missing values for the independent variables in the National Health Screening Examination (NHSE)

  • Regarding the results by each type of cancer, thyroid cancer was highly associated with GDM (HR = 1.27, 95% CI: 1.05–1.53, p = 0.0120)

Read more

Summary

Introduction

Gestational diabetes mellitus (GDM) is defined as a carbohydrate intolerance of variable severity with onset or first recognition occurring during pregnancy [1,2]. The prevalence of GDM is about 6–7%. In the United States and 5.6% in South Korea, and the global prevalence of GDM is increasing [1,3,4,5]. Pregnancy is normally accompanied by progressive insulin resistance due to a combination of increased maternal adiposity and the insulin-desensitizing effects of diabetogenic placental hormones, such as the human growth hormone, corticotropin-releasing hormones, placental lactogen, and progesterone [6]. Most pregnant women are able to compensate for this condition through increased insulin secretion, women with GDM become hyperglycemic, which may cause various chronic metabolic abnormalities [7]. The hyperglycemic effects of placental hormones dissipate rapidly and most women with GDM revert back to their pre-pregnancy glycemic status almost immediately; Int. J. Public Health 2018, 15, 2646; doi:10.3390/ijerph15122646 www.mdpi.com/journal/ijerph

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call